JP2022537658A5 - - Google Patents
Info
- Publication number
- JP2022537658A5 JP2022537658A5 JP2021572305A JP2021572305A JP2022537658A5 JP 2022537658 A5 JP2022537658 A5 JP 2022537658A5 JP 2021572305 A JP2021572305 A JP 2021572305A JP 2021572305 A JP2021572305 A JP 2021572305A JP 2022537658 A5 JP2022537658 A5 JP 2022537658A5
- Authority
- JP
- Japan
- Prior art keywords
- domain
- sequence
- seq
- polypeptide
- nmdar
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP19178541 | 2019-06-05 | ||
| EP19178541.9 | 2019-06-05 | ||
| PCT/EP2020/065606 WO2020245343A1 (en) | 2019-06-05 | 2020-06-05 | Chimeric autoantibody receptor (caar) that binds autoantibodies targeting the central nervous system in neurological autoimmune disease |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022537658A JP2022537658A (ja) | 2022-08-29 |
| JP2022537658A5 true JP2022537658A5 (https=) | 2023-06-09 |
| JP7702884B2 JP7702884B2 (ja) | 2025-07-04 |
Family
ID=66857629
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021572305A Active JP7702884B2 (ja) | 2019-06-05 | 2020-06-05 | 神経学的自己免疫疾患における中枢神経系を標的とする自己抗体に結合するキメラ自己抗体受容体（ｃａａｒ） |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP3980458A1 (https=) |
| JP (1) | JP7702884B2 (https=) |
| CN (1) | CN114008204B (https=) |
| CA (1) | CA3141509A1 (https=) |
| WO (1) | WO2020245343A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112457415A (zh) * | 2020-12-14 | 2021-03-09 | 成都仕康美生物科技有限公司 | 靶向MOG的嵌合抗原受体、编码基因、CAR-Tregs细胞及其制备方法、用途 |
| FR3120866B1 (fr) * | 2021-03-19 | 2025-02-28 | Univ Toulouse 3 Paul Sabatier | Molécule hybride comprenant un peptide citrulliné dérivé de la fibrine et un anticorps ou fragment d’anticorps se liant à CD38 et/ou CD138, et ses utilisations |
| JP2024545870A (ja) * | 2021-12-15 | 2024-12-13 | シャンハイ シンヴィダ バイオテクノロジー カンパニー リミテッド | 血小板減少症を治療するための製品及び方法 |
| CN114957446B (zh) * | 2022-05-31 | 2023-09-15 | 陕西脉元生物科技有限公司 | 与nmdar脑炎患者中的自身抗体结合的nmdar突变体及其构建方法 |
| CN120485285A (zh) * | 2025-07-18 | 2025-08-15 | 天津医科大学总医院 | 一种质粒载体、嵌合mog抗体受体t细胞及其应用 |
| CN120624489B (zh) * | 2025-08-18 | 2025-12-02 | 天津医科大学总医院 | 一种嵌合aqp4抗体受体、caar-t细胞及应用 |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5858358A (en) | 1992-04-07 | 1999-01-12 | The United States Of America As Represented By The Secretary Of The Navy | Methods for selectively stimulating proliferation of T cells |
| US6534055B1 (en) | 1988-11-23 | 2003-03-18 | Genetics Institute, Inc. | Methods for selectively stimulating proliferation of T cells |
| US6905680B2 (en) | 1988-11-23 | 2005-06-14 | Genetics Institute, Inc. | Methods of treating HIV infected subjects |
| US6352694B1 (en) | 1994-06-03 | 2002-03-05 | Genetics Institute, Inc. | Methods for inducing a population of T cells to proliferate using agents which recognize TCR/CD3 and ligands which stimulate an accessory molecule on the surface of the T cells |
| US7175843B2 (en) | 1994-06-03 | 2007-02-13 | Genetics Institute, Llc | Methods for selectively stimulating proliferation of T cells |
| US7067318B2 (en) | 1995-06-07 | 2006-06-27 | The Regents Of The University Of Michigan | Methods for transfecting T cells |
| US6692964B1 (en) | 1995-05-04 | 2004-02-17 | The United States Of America As Represented By The Secretary Of The Navy | Methods for transfecting T cells |
| ATE466948T1 (de) | 1997-03-11 | 2010-05-15 | Univ Minnesota | Dns-basiertes transposon-system für die einführung von nucleinsäure in die dns einer zelle |
| EP1146898A1 (en) * | 1999-01-22 | 2001-10-24 | Matthew John During | Vaccine-mediated treatment of neurological disorders |
| KR20030032922A (ko) | 2000-02-24 | 2003-04-26 | 싸이트 테라피스 인코포레이티드 | 세포의 동시 자극 및 농축 |
| US7572631B2 (en) | 2000-02-24 | 2009-08-11 | Invitrogen Corporation | Activation and expansion of T cells |
| US6867041B2 (en) | 2000-02-24 | 2005-03-15 | Xcyte Therapies, Inc. | Simultaneous stimulation and concentration of cells |
| US6797514B2 (en) | 2000-02-24 | 2004-09-28 | Xcyte Therapies, Inc. | Simultaneous stimulation and concentration of cells |
| US7634360B2 (en) * | 2003-09-23 | 2009-12-15 | Prediction Sciences, LL | Cellular fibronectin as a diagnostic marker in stroke and methods of use thereof |
| ES2443490T3 (es) * | 2006-08-15 | 2014-02-19 | The Trustees Of The University Of Pennsylvania | Métodos y composiciones para el diagnóstico y tratamiento de la encefalitis autoinmune o la epilepsia |
| EP2160461B1 (en) | 2007-07-04 | 2012-08-08 | Max-Delbrück-Centrum für Molekulare Medizin (MDC) | Hyperactive variants of the transposase protein of the transposon system sleeping beauty |
| CN101874895B (zh) * | 2009-02-17 | 2013-01-02 | 南京大学医学院附属鼓楼医院 | Cart作为制备治疗阿尔茨海默病药物的应用 |
| CA2819345A1 (en) * | 2010-11-29 | 2012-06-07 | Kenneth Blum | Methods to assess treatment outcomes in reward deficiency syndrome (rds) behaviors utilizing expression profiling |
| US8648198B2 (en) * | 2011-01-19 | 2014-02-11 | Cold Spring Harbor Laboratory | Phenylethanolamine-based NMDA receptor antagonists |
| CN113604491A (zh) * | 2014-05-02 | 2021-11-05 | 宾夕法尼亚大学董事会 | 嵌合自身抗体受体t细胞的组合物和方法 |
| GB201409234D0 (en) | 2014-05-23 | 2014-07-09 | Isis Innovation | Method |
| RU2018109230A (ru) * | 2015-08-17 | 2019-09-19 | ДОЙЧЕС ЦЕНТРУМ ФЮР НОЙРОДЕГЕНЕРАТИВЕ ЭРКРАНКУНГЕН е.Ф. (ДЦНЭ) | Антитело, или фрагмент антитела, или неиммуноглобулиновый каркас, связывающийся с областью связывания антитела против рецептора n-метил-d-аспартата (nmda) |
| SG10202012157QA (en) * | 2016-06-07 | 2021-01-28 | Max Delbrueck Centrum Fuer Molekulare Medizin Helmholtz Gemeinschaft | Chimeric antigen receptor and car-t cells that bind bcma |
| CN107857712B (zh) * | 2016-09-22 | 2022-09-09 | 烟台益诺依生物医药科技有限公司 | (r)-3-甲基-2-(3-氧代酰胺基)正丁酸酯 |
| WO2018127585A1 (en) * | 2017-01-06 | 2018-07-12 | Txcell | Monospecific regulatory t cell population with cytotoxicity for b cells |
| EP3346001A1 (en) | 2017-01-06 | 2018-07-11 | TXCell | Monospecific regulatory t cell population with cytotoxicity for b cells |
| CN112423793A (zh) * | 2018-06-05 | 2021-02-26 | 宾夕法尼亚大学董事会 | 肌肉特异性激酶嵌合自身抗体受体细胞的组合物和方法 |
-
2020
- 2020-06-05 WO PCT/EP2020/065606 patent/WO2020245343A1/en not_active Ceased
- 2020-06-05 JP JP2021572305A patent/JP7702884B2/ja active Active
- 2020-06-05 CN CN202080041341.7A patent/CN114008204B/zh active Active
- 2020-06-05 CA CA3141509A patent/CA3141509A1/en active Pending
- 2020-06-05 EP EP20732162.1A patent/EP3980458A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022537658A5 (https=) | ||
| US12435118B2 (en) | Chimeric antigen receptor and natural killer cells expressing same | |
| JP2023059873A5 (https=) | ||
| JP2022109953A5 (https=) | ||
| US11180553B2 (en) | Chimeric antigen receptor | |
| JP2025060882A5 (https=) | ||
| JP2025065142A5 (https=) | ||
| JP2023071729A5 (https=) | ||
| JP2021512615A5 (https=) | ||
| EP1973573B1 (en) | Methods and compositions for expanding t regulatory cells | |
| JP2020513829A5 (https=) | ||
| JP2021522790A5 (https=) | ||
| JP2020529841A5 (https=) | ||
| FI3823665T3 (fi) | BCMA-spesifisiä kimeerisiä antigeenireseptoreita ja niiden käyttöjä | |
| JP2020511136A5 (https=) | ||
| RU2018140056A (ru) | Композиции и способы с использованием т-клеток с химерным рецептором аллоантигена | |
| JP2023534808A5 (https=) | ||
| JP2023537326A5 (https=) | ||
| Fremont et al. | Biophysical studies of T-cell receptors and their ligands | |
| JP2018525006A5 (https=) | ||
| JP2018508219A5 (https=) | ||
| JP2018523484A5 (https=) | ||
| JP2019513394A5 (https=) | ||
| JP2021520820A5 (https=) | ||
| JP2022515331A5 (https=) |